GLP-1 (glucagon-like peptide 1) receptor agonist (semaglutide, Ozempic, Rybelsus, Wegovy) not only produce weight loss but also improve other metabolic







GLP-1 Receptor Agonist & Metabolic Side Effects [speed diet pills]

GLP-1 Receptor Agonist & Metabolic Side Effects [speed diet pills]

| 1h 28m 28s | Video has closed captioning.

GLP-1 (glucagon-like peptide 1) receptor agonist (semaglutide, Ozempic, Rybelsus, Wegovy) not only produce weight loss but also improve other metabolic variables, such as blood sugar, blood pressure, and lipids. Here, Dr. Rajnish Mago reviews how you might utilize GLP-1 receptor agonist to help manage antipsychotic-induced metabolic side effects. You can enjoy the full lecture, titled “Balancing the Scales: Antipsychotic Side Effects”, here: Learn about upcoming NEI Meetings: Stay updated with email alerts: Interested in Psychopharmacology? Check out the NEI Master Psychopharmacology Program: Follow us on Facebook: Follow us on LinkedIn: Follow us on X: Follow us on Instagram: 🎙 Listen to NEI Podcast: Copyright © Neuroscience Education Institute. All rights reserved.

Aired: May 28, 2025

Rating: TV-14

Buy Now:

Problems Playing Video? | Closed Captioning

Learn About Midwifery Today

Blog

Learn About Midwifery Today

Read the Modern Day Midwives Blog and learn more about our bloggers, all experienced midwives.

Read now